Merck Shelanno announced on the 23rd in Beijing，It will invest about 1.5 billion yuan in the next 4 years to establish an international drug research and development center in Beijing，Lead of drug research and development work in China and other countries in Asia，Including pharmaceutical genetics research and biological analysis activities。 
    R & D Center plans to recruit more than 200 employees in China to carry out research and development activities。 
    The person in charge Stake Sports Bettingstake sports betting appof Merck Shelanino said，Creation of China R & D Center，The aimed to further expand the investment in China，Continuously meet China's growing health care needs，At the same time, more Chinese R & D talents will be recruited at the same time、Carry out more R & D projects，Incorporate it into Merck Shelanino's global research and development system。 
    Merck Shelanino is a prescription pharmaceutical business department under the Merck Company of Pharmaceutical and Chemical Group，The headquarters is located in Geneva, Switzerland。The company's annual R & D investment exceeds 1 billion euros，Currently in Germany、There are R stake sports betting appstake betting app& D centers in Switzerland and the United States。